ロード中...
Drug screening to target nuclear orphan receptor NR4A2 for cancer therapeutics
BACKGROUND: Our previous study suggested NR4A2, a subfamily member of orphan nuclear receptors, is essential for survival of human cancer cells such as mucoepidermoid carcinoma (MEC). METHODS: We conducted high throughput drug screening for NR4A2 inhibitors as a novel therapeutic modality. Positive...
保存先:
| 出版年: | Transl Lung Cancer Res |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AME Publishing Company
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5653521/ https://ncbi.nlm.nih.gov/pubmed/29114475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2017.07.02 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|